Novartis tries to get U.S. ban lifted on sale of Neupogen copycat

WASHINGTON (Reuters) - Novartis AG unit Sandoz asked a U.S. appeals court on Wednesday to lift a preliminary injunction barring it from selling its biosimilar Zarxio, a cheaper version of a drug that fends off infections in cancer patients.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news